Dr. Jonathan Chow, M.D

NPI: 1275809261
Total Payments
$328,413
2024 Payments
$22,778
Companies
7
Transactions
255
Medicare Patients
417
Medicare Billing
$132,696

Payment Breakdown by Category

Other$218,993 (66.7%)
Consulting$78,399 (23.9%)
Travel$24,757 (7.5%)
Food & Beverage$6,264 (1.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $137,808 43 42.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $81,184 29 24.7%
Consulting Fee $78,399 14 23.9%
Travel and Lodging $24,757 76 7.5%
Food and Beverage $6,264 90 1.9%
Unspecified $0 3 0.0%

Payments by Type

General
$328,413
252 transactions
Ownership
$0
3 transactions

Top Paying Companies

Company Total Records Latest Year
La Jolla Pharmaceutical Company $243,653 222 $0 (2024)
ExThera Medical Corporation $67,719 18 $0 (2023)
HemoSonics LLC $16,424 11 $0 (2024)
Partner Therapeutics, Inc. $350.00 1 $0 (2020)
Shionogi Inc $123.13 1 $0 (2022)
Chiesi USA, Inc. $102.85 1 $0 (2019)
Edwards Lifesciences Corporation $40.09 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $22,778 8 HemoSonics LLC ($15,282)
2023 $87,685 27 ExThera Medical Corporation ($61,426)
2022 $55,791 31 La Jolla Pharmaceutical Company ($49,139)
2021 $49,941 40 La Jolla Pharmaceutical Company ($49,401)
2020 $25,357 38 La Jolla Pharmaceutical Company ($25,007)
2019 $22,076 43 La Jolla Pharmaceutical Company ($21,865)
2018 $64,785 68 La Jolla Pharmaceutical Company ($64,785)

All Payment Transactions

255 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
11/06/2024 La Jolla Pharmaceutical Company GIAPREZA (Drug) Honoraria Cash or cash equivalent $7,277.00 General
Category: EMERGENT HYPOTENSION
11/06/2024 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $121.82 General
Category: EMERGENT HYPOTENSION
11/06/2024 La Jolla Pharmaceutical Company GIAPREZA (Drug) Travel and Lodging Cash or cash equivalent $97.33 General
Category: EMERGENT HYPOTENSION
08/22/2024 HemoSonics LLC QUNATRA QPLUS SYSTEM (Device), QUANTRA QPLUS SYSTEM Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,225.00 General
Category: HEMATOLOGY
06/06/2024 HemoSonics LLC QUNATRA QPLUS SYSTEM (Device), QUANTRA QPLUS SYSTEM Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,225.00 General
Category: HEMATOLOGY
05/19/2024 HemoSonics LLC QUNATRA QPLUS SYSTEM (Device), QUANTRA QPLUS SYSTEM Food and Beverage In-kind items and services $42.75 General
Category: HEMATOLOGY
03/14/2024 HemoSonics LLC QUNATRA QPLUS SYSTEM (Device), QUANTRA QPLUS SYSTEM Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,438.00 General
Category: HEMATOLOGY
03/14/2024 HemoSonics LLC QUNATRA QPLUS SYSTEM (Device), QUANTRA QPLUS SYSTEM Travel and Lodging Cash or cash equivalent $1,350.99 General
Category: HEMATOLOGY
10/13/2023 HemoSonics LLC QUANTRA QPLUS SYSTEM (Device), QUANTRA QPLUS SYSTEM Food and Beverage In-kind items and services $196.40 General
Category: HEMATOLOGY
09/05/2023 HemoSonics LLC QUANTRA QPLUS SYSTEM (Device), QUANTRA QPLUS SYSTEM Food and Beverage In-kind items and services $101.48 General
Category: HEMATOLOGY
05/22/2023 ExThera Medical Corporation Consulting Fee Cash or cash equivalent $15,000.00 General
05/10/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Honoraria Cash or cash equivalent $7,277.00 General
Category: EMERGENT HYPOTENSION
05/10/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Honoraria Cash or cash equivalent $3,119.00 General
Category: EMERGENT HYPOTENSION
05/02/2023 ExThera Medical Corporation Travel and Lodging Cash or cash equivalent $2,057.34 General
04/25/2023 ExThera Medical Corporation Consulting Fee Cash or cash equivalent $15,000.00 General
04/25/2023 ExThera Medical Corporation Food and Beverage Cash or cash equivalent $47.10 General
04/17/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Travel and Lodging Cash or cash equivalent $275.68 General
Category: EMERGENT HYPOTENSION
04/17/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Travel and Lodging Cash or cash equivalent $233.90 General
Category: EMERGENT HYPOTENSION
04/17/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $114.71 General
Category: EMERGENT HYPOTENSION
04/17/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $30.48 General
Category: EMERGENT HYPOTENSION
04/05/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Honoraria Cash or cash equivalent $5,198.00 General
Category: EMERGENT HYPOTENSION
03/29/2023 ExThera Medical Corporation Consulting Fee Cash or cash equivalent $15,000.00 General
03/28/2023 ExThera Medical Corporation Travel and Lodging Cash or cash equivalent $2,534.68 General
03/21/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Travel and Lodging Cash or cash equivalent $1,046.64 General
Category: EMERGENT HYPOTENSION
03/21/2023 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $57.13 General
Category: EMERGENT HYPOTENSION

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 78 156 $83,081 $25,571
2022 3 119 208 $113,294 $38,050
2021 4 135 205 $109,010 $35,339
2020 2 85 251 $85,789 $33,736
Total Patients
417
Total Services
820
Medicare Billing
$132,696
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 64 120 $73,961 $21,767 29.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 14 36 $9,120 $3,805 41.7%
99291 Critical care, first 30-74 minutes Facility 2022 94 174 $101,442 $33,789 33.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 14 14 $6,832 $2,504 36.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 11 20 $5,020 $1,757 35.0%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 84 154 $85,683 $30,108 35.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 21 21 $10,248 $3,602 35.2%
36556 Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled Facility 2021 12 12 $8,021 $915.96 11.4%
36620 Insertion of arterial catheter for blood sampling or infusion, accessed through the skin Facility 2021 18 18 $5,058 $712.44 14.1%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 48 143 $71,191 $27,179 38.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 37 108 $14,598 $6,558 44.9%

About Dr. Jonathan Chow, M.D

Dr. Jonathan Chow, M.D is a Critical Care Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1275809261.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Chow, M.D has received a total of $328,413 in payments from pharmaceutical and medical device companies, with $22,778 received in 2024. These payments were reported across 255 transactions from 7 companies. The most common payment nature is "Honoraria" ($137,808).

As a Medicare-enrolled provider, Chow has provided services to 417 Medicare beneficiaries, totaling 820 services with total Medicare billing of $132,696. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Location Washington, DC
  • Active Since 03/24/2012
  • Last Updated 11/03/2023
  • Taxonomy Code 207LC0200X
  • Entity Type Individual
  • NPI Number 1275809261

Products in Payments

  • GIAPREZA (Drug) $240,746
  • QUNATRA QPLUS SYSTEM (Device) $15,518
  • XERAVA (Drug) $2,815
  • QUANTRA QPLUS SYSTEM (Device) $797.88
  • Leukine (Drug) $350.00
  • Fetroja (Drug) $123.13
  • Quantra QPlus System (Device) $108.43
  • CLEVIPREX (Drug) $102.85
  • HemoSphere (Device) $40.09

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Washington